These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Downstaging of esophageal carcinoma after preoperative radio- and chemotherapy]. Staar S Strahlenther Onkol; 1996 Dec; 172(12):693-5. PubMed ID: 8992641 [No Abstract] [Full Text] [Related]
45. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma. Gao XS; Qiao XY; Yang XR; Asaumi J; Zhou ZG; Wang YD; Zhou DA; Wan J; Kuroda M; Kishi K; Kawasaki S; Hiraki Y Oncol Rep; 2002; 9(4):767-72. PubMed ID: 12066206 [TBL] [Abstract][Full Text] [Related]
46. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]. Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ; Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962 [TBL] [Abstract][Full Text] [Related]
47. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma. Qiao XY; Wang W; Zhou ZG; Gao XS; Chang JY Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):396-402. PubMed ID: 17855004 [TBL] [Abstract][Full Text] [Related]
48. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460 [TBL] [Abstract][Full Text] [Related]
49. The quality of swallowing for patients with operable esophageal carcinoma: a randomized trial comparing surgery with radiotherapy. Badwe RA; Sharma V; Bhansali MS; Dinshaw KA; Patil PK; Dalvi N; Rayabhattanavar SG; Desai PB Cancer; 1999 Feb; 85(4):763-8. PubMed ID: 10091752 [TBL] [Abstract][Full Text] [Related]
50. The present place of radiation therapy in the management of esophageal cancer. Pearson JG Prog Clin Cancer; 1970; 4():257-71. PubMed ID: 4984641 [No Abstract] [Full Text] [Related]
51. Chemoradiation as primary management of esophageal cancer. Coia LR Semin Oncol; 1994 Aug; 21(4):483-92. PubMed ID: 8042046 [No Abstract] [Full Text] [Related]
52. Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy. Fang FM; Tsai WL; Chiu HC; Kuo WR; Hsiung CY Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1394-404. PubMed ID: 15050315 [TBL] [Abstract][Full Text] [Related]
53. [Esophageal carcinoma. Results of telecobalttherapy in comparison with conventional x-ray depth therapy]. Eichhorn HJ; Rotte KH Med Klin; 1966 Apr; 61(14):539-42. PubMed ID: 5987558 [No Abstract] [Full Text] [Related]
54. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928 [TBL] [Abstract][Full Text] [Related]
55. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077 [TBL] [Abstract][Full Text] [Related]
56. [Index of the lesion as a quantitative criterion for radiation pathomorphosis]. Lavnikova GA Med Radiol (Mosk); 1979 Dec; 24(12):14-8. PubMed ID: 513991 [No Abstract] [Full Text] [Related]
57. Evaluation of treatment with respect to radiotherapy: carcinoma of the oesophagus. Shehata WM IMJ Ill Med J; 1979 Apr; 155(4):215-7. PubMed ID: 35491 [No Abstract] [Full Text] [Related]